Hospitals to put doctors' relationships with pharmaceutical companies under the microscope
The University of Colorado School of Medicine, National Jewish and Denver Health are all reviewing and tightening ethics rules as dozens of doctors defy reporting requirements for drug-company payments that can reach well into six figures.
National Jewish, most of whose doctors have dual roles with CU, said it is conducting its own rules review after a preliminary CU report said doctors were testing ethical boundaries and ignoring or disobeying disclosure rules.
"The status quo is no longer acceptable," said Richard Krugman, dean of the CU medical school.
Denver Health spokeswoman Dee Martinez said the hospital system is also reviewing its ethics policies for potential revision, given the recent outcry about pharmaceutical- company spending.
- Half of All Primary Care, Internal Medicine Jobs Unfilled in 2013
- How Digital Strategy Shapes Patient Engagement at Boston Children's Hospital
- CFO Exchange: Smartphones Poised to Disrupt Healthcare, Says Topol
- CNO on Hospital Redesign: 'You Can't Over-Communicate'
- Some Cancer Hospitals' Quality Data Will Soon Be Public
- CA Powers Up $80M HIE to 'Create Value in the Data'
- TJC Warns Hospitals of Deadly Medical Tubing Mistakes
- 3 Traits Personality Assessments Can't Reveal
- PA Ranks See 'Phenomenal Growth,' Lack of Diversity
- Consumerism Drives Healthcare Branding, Rebranding Efforts